Cognitive Behavioral Therapy for Complicated Grief

Not Applicable

Completed

• Conditions: Grief
• Interventions: Behavioral: Cognitive Behavioral Therapy for Complicated Grief

• Registration Number: NCT01433653
• Lead Sponsor: Ludwig-Maximilians - University of Munich

Brief Summary

The purpose of this study is to determine whether cognitive behavioral therapy (CG-CBT) for complicated grief is superior to wait list condition in patients with comorbid complicated grief. To evaluate the effect pre-post changes for patients in the CG-CBT-group will be compared to changes in the wait list group.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-05
• Primary Completion: 2011-02
• Study Completion: 2011-02
• Study First Submitted: 2011-07-18
• Study First Submitted QC: 2011-09-13
• Study First Posted: 2011-09-14
• Status Verified: 2015-06
• Last Update Submitted: 2015-06-08
• Last Update Posted: 2015-06-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

• age complicated grief diagnosis

Exclusion Criteria

• acute suicidality

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
CG-CBT	Cognitive Behavioral Therapy for Complicated Grief	-

Primary Outcome Measures

Name	Time	Method
PG-13 (Prolonged Grief Interview - 13 Item version)	Change between intake (t1) and end of treatment (t2) in complicated grief severity within 5 months. t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2)

Secondary Outcome Measures

Name	Time	Method
Comorbid Diagnoses by DIA-X-Interview	Change between intake (t1) and end of treatment (t2) in number of comorbid psychiatric diagnoses within 5 months; t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2)
Symptom Checklist 90 revised (SCL-90R; Subscale General Symptom Index, GSI)	Change between intake (t1) and end of treatment (t2) in general distress symptoms within 5 months. t1= before treatment or wait list begins, t2 = 4 months after t1 (end of treatment, end of waitlist), t3 = follow-up (1.5 years after t2)

Trial Locations

Locations (1)

LMU; 🇩🇪 Munich, Germany